VILINBIO

Vilin Bio Med Share Price

 

Stock Hit Upper Circuit

 

Start SIP in VILINBIO

Start SIP

Performance

  • Low
  • ₹29
  • High
  • ₹29
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹33
  • Open Price₹29
  • Previous Close₹28
  • Volume32,000
  • 50 DMA₹23.98
  • 100 DMA₹24.16
  • 200 DMA₹23.90

Investment Returns

  • Over 1 Month + 42.72%
  • Over 3 Month + 9.06%
  • Over 6 Month + 15.37%
  • Over 1 Year + 54.55%

Smart Investing Starts Here Start SIP with Vilin Bio Med for Steady Growth!

Invest Now

Vilin Bio Med Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 180.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 40
  • P/B Ratio
  • 1.7
  • Average True Range
  • 1.17
  • EPS
  • 0.16
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.93
  • RSI
  • 67.02
  • MFI
  • 80.24

Vilin Bio Med Financials

Vilin Bio Med Technicals

EMA & SMA

Current Price
₹28.90
+ 1.35 (4.9%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹24.81
  • 50 Day
  • ₹23.98
  • 100 Day
  • ₹24.16
  • 200 Day
  • ₹23.90

Resistance and Support

28.9 Pivot Speed
  • R3 28.90
  • R2 28.90
  • R1 28.90
  • S1 28.90
  • S2 28.90
  • S3 28.90

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vilin Bio Med Ltd has an operating revenue of Rs. 40.28 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 2% needs improvement, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 47 which is a POOR score indicating inconsistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 69 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vilin Bio Med Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-10 Fund Raising & Others To consider other business matters.
2025-11-12 Quarterly Results
2025-10-14 Others To consider other business matters.
2025-05-17 Audited Results
2025-01-10 To consider Fund Raising & Others To consider other business matters.

Vilin Bio Med F&O

Vilin Bio Med Shareholding Pattern

63.65%
33.96%
2.39%

About Vilin Bio Med

  • NSE Symbol
  • VILINBIO
  • BSE Symbol
  • Managing Director
  • Mr. Madhusudhan Yadamakanti Reddy
  • ISIN
  • INE0L4V01013

Similar Stocks to Vilin Bio Med

Vilin Bio Med FAQs

Vilin Bio Med share price is ₹28 As on 26 January, 2026 | 06:59

The Market Cap of Vilin Bio Med is ₹40.3 Cr As on 26 January, 2026 | 06:59

The P/E ratio of Vilin Bio Med is 180.4 As on 26 January, 2026 | 06:59

The PB ratio of Vilin Bio Med is 1.7 As on 26 January, 2026 | 06:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23